Interest in the development of medicines to alleviate or cure rare
diseases has increased due to positive actions taken by global
regulatory agencies. Alastair MacDonald, Executive Director, Real
World and Late Phase, INC Research, gives an insight into the
interest in the development of medicines to alleviate or cure, ensuring
that the correct clinical environment is in place and understanding
how to drive adoption of the relevant technologies.